Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 505 of 1,261

  1. US 10260054

    Engineered organophosphorus acid anhydrolases and methods of use thereof

    The United States of America as represented by the Secretary of the Army · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  2. US 10261094

    Competitive ligand binding assay for detecting neutralizing antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  3. US 10260101

    C-kit oncogene mutations in melanoma

    The Regents of the University of California · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  4. US 10259846

    Bouvardin derivatives and therapeutic uses thereof

    The Regents of the University of Colorado · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  5. US 10259845

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  6. US 10259826

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  7. US 10259824

    Complement C3d-binding compounds

    The Regents of the University of California · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  8. US 10259786

    Psychotropic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  9. US 10259781

    Imaging agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  10. US 10258699

    Angiopep and derivatives thereof for imaging amyloids

    UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  11. US 10258655

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  12. US 10258682

    Attenuated chlamydia vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  13. US 10258678

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  14. US 10258635

    Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases

    Aphios Corporation · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  15. US 10258631

    Formulations of testosterone and methods of treatment therewith

    The Board of Regents of the University of Texas System · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  16. US 10258630

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  17. US 10258629

    Liposomal drug encapsulation

    The Regents of the University of California · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  18. US 10258606

    Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  19. US 10258600

    Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

    Northwestern University · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  20. US 10258624

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  21. US 10258613

    Compositions for treating retinal degeneration and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  22. US 10258576

    Particulate comprising a calcium-containing compound and a sugar alcohol

    TAKEDA AS · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  23. US 10258567

    Vaginal probiotic products and related processes

    Grace Procurements LLC · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  24. US 10259780

    Treatment of cataplexy

    Jazz Pharmaceuticals International III Limited · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.